Comparison of efficacy and safety of Ferric carboxy maltose and Iron sucrose for the treatment of Iron Deficiency anemia in pregnancy

COMPARISON OF EFFICACY AND SAFETY OF FERRIC CARBOXYMALTOSE AND IRON SUCROSE FOR TREATMENT OF IRON DEFICIENCY ANEMIA IN PREGNANCY - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075061

Enrollment

1000

Registered

2024-10-10

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: FERRIC CARBOXYMALTOSE: 500mg IV 3 doses, 6 MONTHS Control Intervention1: IRON SUCROSE: 200mg IV 6 doses, 6 MONTHS

Eligibility

Inclusion criteria

Inclusion criteria: All AN mothers between 14-32weeks of gestation with moderate anemia

Exclusion criteria

Exclusion criteria: All AN mothers before 14weeks and after 32weeks of gestation with moderate anemia. All AN mothers with severe anemia in all 3 trimesters. AN mothers who received blood transfusion in this pregnancy. AN mothers hypersensitive to any iron preparation. AN mothers with liver disorder like Jaundice, cirrhosis. AN mother’s with acute Cardiac failure or Renal failure. AN mother’s with known case of hemolytic anemia.

Design outcomes

Primary

Measure	Time frame
Rate of Increase in HBTimepoint: AFTER 3WEEKS	—

Secondary

Measure	Time frame
EFFECACY AND SAFETY OF FERRIC CARBOXY MALTOSE AND IRON SUCROSE IN PREGNANCYTimepoint: 6MONTHS	—

Countries

India

Contacts

Public ContactB Nithya Devi

Government Medical College and Hospital Tiruppur

m72sundari@gmail.com09894460190

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026